An observational study of Avastin (bevacizumab) in combination with chemotherapy for treatment of metastatic or locally advanced and unresectable colorectal adenocarcinoma
Phase of Trial: Phase IV
Latest Information Update: 24 Nov 2014
At a glance
- Drugs Bevacizumab (Primary)
- Indications Colorectal cancer
- Focus Therapeutic Use
- Sponsors Genentech
- 26 Mar 2013 Status changed from active, no longer recruiting to completed as reported by ClinicalTrials.gov.
- 15 Dec 2005 New trial record.